https://rheumatologydigest.org/tags/prevention/Recent content in Prevention on Rheumatology DigestHugoen-usTue, 28 Jul 2026 05:00:00 +0530https://rheumatologydigest.org/posts/treat-earlier-5-year-data/Tue, 28 Jul 2026 05:00:00 +0530https://rheumatologydigest.org/posts/treat-earlier-5-year-data/Five-year data from the TREAT EARLIER trial show that a time-limited intervention (one glucocorticoid injection plus 12 months of methotrexate) in clinically suspect arthralgia produced durable benefit in ACPA-negative individuals at increased risk — RA in 9% vs 32%, NNT 4 — but nothing lasting in ACPA-positive individuals, splitting the at-risk phase into two diseases with two different answers.